Lyfebulb
Lyfebulb is an innovation accelerator that focuses on enhancing the lives of individuals affected by chronic diseases. By directly engaging with patient communities and their care partners, the company generates valuable insights and develops new solutions tailored to their needs. Lyfebulb operates an online digital platform that aims to reduce the burden of chronic disease through education, innovation, and connectivity. Through this patient empowerment approach, the company seeks to create and introduce groundbreaking products to the healthcare market, effectively bridging the gap between patients and the broader healthcare industry.
1 past transactions
UE LifeSciences
Grant in 2019
UE LifeSciences is a growth-stage FemTech company focused on preventive oncology, specializing in non-invasive breast cancer detection technologies. The company has developed a portable screening device that facilitates early-stage detection of breast cancer, thereby enabling timely treatment for patients. Its hallmark product has received regulatory clearance and has been validated through independent trials, leading to its commercial scaling across multiple markets. With a high-margin, pay-per-use revenue model, UE LifeSciences is also collaborating with major pharmaceutical companies to expand its reach into national-scale markets. The company maintains a robust product pipeline, with ongoing innovations targeting breast and cervical cancer detection, positioning it as a significant player in the healthcare technology sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.